WHAT IS GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD, G-6-PD), QUANTITATIVE TEST?

WHAT IS GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD, G-6-PD), QUANTITATIVE TEST?

Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme normally present in the erythrocytes. This enzyme is part of the pentose phosphate pathway that metabolises glucose and functions to protect cells from damage by oxidising agents. This test measures G6PD levels in red blood cells, thereby detecting deficiencies of this enzyme. G6PD deficiency is a sex-linked genetic disorder found mostly in males that results in hyperbilirubinemia, jaundice, and hemolysis of erythrocytes, producing anaemia after the receipt of certain drugs. Drugs that may precipitate hemolytic episodes in affected individuals include acetanilide, acetyl phenylhydrazine, antipyrine, ascorbic acid, aspirin, chloramphenicol, nalidixic acid, naphthalene, nitrofuran, nitrofurantoin, pentaquine, phenacetin, phenylhydrazine, primaquine, probenecid, quinacrine, quinidine, quinine, sulfonamides, and vitamin K. Other precipitants include diabetic acidosis, fava bean ingestion, infections (viral, bacterial), and septicemia. 

KNOWLEDGE BASE
About Genomic Medicine UK

Genomic Medicine UK is the home of comprehensive genomic testing in London. Our consultant medical doctors work tirelessly to provide the highest standards of medical laboratory testing for personalised medical treatments, genomic risk assessments for common diseases and genomic risk assessment for cancers at an affordable cost for everybody. We use state-of-the-art modern technologies of next-generation sequencing and DNA chip microarray to provide all of our patients and partner doctors with a reliable, evidence-based, thorough and valuable medical service.

X